Zachary J Frangos

6PUBLICATIONS
35CO-AUTHORS
Medical microbiology not elsewhere classifiedGlycoconjugatesToxicology (incl. clinical toxicology)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 24, 2026
Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects.

|Apr 15, 2026
Identification of Non-competitive and Reversible Inhibitors of Glycine Transporter 2: A Promising Non-opioid Therapeutic Strategy for Neuropathic Pain.

|Apr 01, 2026
A µ-opioid receptor superagonist analgesic with minimal adverse effects.

Juan L Gomez, Emilya N Ventriglia, Zachary J Frangos

|Feb 16, 2026
A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects.

Ryan P Cantwell Chater, Julian Peiser-Oliver, Tanmay K Pati

|Dec 03, 2025
A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects.

Ryan P Cantwell Chater, Julian Peiser-Oliver, Tanmay K Pati

|Jul 19, 2023
Novel Phenylene Lipids That Are Positive Allosteric Modulators of Glycine Receptors and Inhibitors of Glycine Transporter 2.

Casey I Gallagher, Zachary J Frangos, Diba Sheipouri

Pageof 1

Frequent Collaborators

5 joint publications

Michael Michaelides

4 joint publications

Robert J Vandenberg

4 joint publications

Anna E Tischer

3 joint publications

Ryan P Cantwell Chater